‘Living drug’ offers hope to terminal blood cancer patients

NHS patients with lymphoma have for the first time been given a pioneering treatment that genetically reprogrammes their immune system to fight cancer. The therapy, called CAR-T, is a “living drug” that is tailor-made for each patient using their body’s own cells
Doctors at King’s College Hospital, London, said some patients were being completely cured in a way that had “never been seen before”. Image copyright
GOSH

Image caption

Yuvan, 11, had CAR-T therapy for acute lymphoblastic leukaemia

One reason the blood cancer work has been easier is down to acceptable collateral damage.

Source: www.bbc.com